Terumo’s $170 Mil. Vascutek Purchase Builds Cardiovascular Offerings
This article was originally published in The Gray Sheet
Executive Summary
Terumo Medical's annual sales will approach $230 mil. through the purchase of Centerpulse's Vascutek vascular graft division. A definitive purchase agreement was announced Oct. 4
You may also be interested in...
Biocompatibles’ Drug-Eluting UFE Treatment Would Be Marketed By Terumo
Biocompatibles International may await development of a drug-eluting version of its Bead Block microspheres therapy before seeking FDA clearance for uterine fibroid embolization (UFE)
Biocompatibles’ Drug-Eluting UFE Treatment Would Be Marketed By Terumo
Biocompatibles International may await development of a drug-eluting version of its Bead Block microspheres therapy before seeking FDA clearance for uterine fibroid embolization (UFE)
Centerpulse Divestiture Plan Complete With Sale Of Heart Valve Biz To Snia
Centerpulse's exit from the cardiovascular market is complete with the Nov. 27 sale of its Carbomedics and Mitroflow mechanical and tissue heart valve units to Milan-based Snia